Safety of One-week, First-line, Standard Triple Therapy for Helicobacter pylori Eradication in a Japanese Population

E-ISSN： 2212-3911|12|2|103-109

ISSN： 1574-8863

Source： Current Drug Safety, Vol.12, Iss.2, 2017-07, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing

By Sivri Bulent Simsek Ilkay Hulagu Saadettin Kadayifci Abdurrahman Tozun Nurdan Akarsu Mesut Uraz Suleyman Savas M. Cemil Koruk Mehmet Bozbas Aysun

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1301-1307

Informa Healthcare

Access to resources Recommend Favorite

Ten‐day triple therapy versus sequential therapy versus concomitant therapy as first‐line treatment for Helicobacter pylori infection

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1134-1139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ultimate eradication rate of H. pylori

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 490-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 768-775

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 581-589

John Wiley & Sons Inc

Access to resources Recommend Favorite